Quarterly report pursuant to Section 13 or 15(d)

Basis of Presentation (Details Textual)

v3.7.0.1
Basis of Presentation (Details Textual) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 9 Months Ended
Apr. 13, 2016
May 15, 2015
Jan. 25, 2016
Mar. 31, 2017
Mar. 31, 2016
Jun. 30, 2016
Basis of Presentation [Line Items]            
Accumulated deficit       $ (67,794)   $ (57,591)
Net Cash Used in Operating Activities       $ (9,398) $ (5,250)  
Stock Issued During Period, Shares, New Issues 6,500,000          
Common Stock, Par or Stated Value Per Share       $ 0.001   $ 0.001
Aspire Capital Fund Llc [Member] | Maximum [Member]            
Basis of Presentation [Line Items]            
Sale of Stock, Consideration Received on Transaction   $ 15,000        
iBio CMO [Member] | Eastern [Member]            
Basis of Presentation [Line Items]            
Stock Issued During Period, Shares, New Issues     3,500,000      
Stock Issued During Period, Shares, Acquisitions     10,000,000 10,000,000    
Common Stock, Par or Stated Value Per Share       $ 0.622    
Class Of Warrants Or Rights Exercised     1,784,000      
Class of Warrant or Right, Exercise Price of Warrants or Rights     $ 0.53      
Proceeds From Capitalization Received     $ 15,000      
Stock Issued During Period, Value, Acquisitions     $ 7,200